Clinical Trials Browser

Phase 3 × INDUSTRY × Bone Neoplasms × Clear all

NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Phase 3 Completed

1,718 enrolled 22 charts

Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

NCT00099177 2017-08-16

A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain

Phase 3 Terminated

Bone Neoplasms, Neoplasm Metastasis, Pain

NCT00099203 2017-08-16

A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease

Phase 3 Terminated

Bone Neoplasms, Neoplasm Metastasis, Pain

NCT02561039 2016-11-02

A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease

Phase 3 Completed

Bone Neoplasms, Neoplasm Metastasis, Pain

NCT02716792 2016-03-23

A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer

Phase 3 Completed

Bone Neoplasms, Neoplasm Metastasis, Pain

NCT00538239 2015-02-13

SUCCEED

Phase 3 Completed

Bone Neoplasms, Sarcoma